In a landmark development that promises to transform diabetes management, the North America and Europe artificial pancreas systems market is projected to exceed a valuation of USD 567.47 million by 2032. This growth trajectory marks a substantial increase from USD 182.71 million in 2022, reflecting a robust compound annual growth rate (CAGR) of 12% over the next decade, according to the latest industry analysis.
Artificial pancreas systems, designed to automate blood sugar management for individuals with type-1 diabetes, represent a groundbreaking advancement in patient care. These innovative systems offer a solution that not only enhances the quality of life for diabetes patients but also ensures more consistent and precise glucose control.
Optimize Your Strategy with Actionable Insights: Access Checkout Comprehensive Reports
“The growing demand for artificial pancreas systems in North America and Europe is a clear indicator of the critical need for innovative and effective diabetes management solutions,” said FMI. “As the incidence of type-1 diabetes increases, so does the urgency for technologies that can deliver both relief and results to patients. This projection is a testament to both the dire need and the trust in the technological advancements in diabetes care.”
The market’s expansion is fueled by continuous advancements in technology, improved healthcare policies, and increased healthcare expenditure dedicated to chronic disease management. Additionally, the rise in awareness and accessibility of advanced diabetic care technologies are playing a crucial role in the accelerated adoption of these systems.
Healthcare providers and industry stakeholders are optimistic about the transformative potential of artificial pancreas systems. This technology promises not only to ease the burden on healthcare systems but also to offer a more liberated lifestyle to patients, significantly reducing daily management challenges and health risks associated with type-1 diabetes.
As we move towards a more tech-driven approach in healthcare, the artificial pancreas systems market in North America and Europe represents a pivotal shift towards automated and more efficient chronic disease management solutions.
Rising Diabetes Prevalence and Economic Impact Set to Boost Demand for Artificial Pancreas Systems in North America and Europe:
- The number of people with diabetes is increasing in North America and Europe, placing a strain on healthcare systems. This is due to factors like lifestyle choices and aging populations.
- Diabetes is expensive to treat, both for individuals and for healthcare systems as a whole. The costs are expected to continue to rise.
- These medical devices are seen as a potential solution to manage diabetes more effectively. They can continuously monitor blood sugar levels and deliver insulin as needed, mimicking a healthy pancreas.
- The report predicts a significant increase in sales of artificial pancreas systems in North America and Europe. This is due to a combination of the factors mentioned above.
Overall, this trend suggests that as diabetes becomes more common, there will be a growing demand for new technologies to help manage the condition. Artificial pancreas systems are one such technology that is expected to play an increasingly important role in diabetes care.
Access the Full Report – Take Your Business Strategy to the Next Level
Competition Landscape:
- Medtronic Plc.
- Johnson and Johnson Services Inc.
- Dexcom Inc.
- Insulet Corporation
- Tandem Diabetes Care Inc.
- Cellnovo
North America and Europe artificial pancreas systems market: segmentation
By Region:
- North America
- Western Europe
- Eastern Europe
By Distribution Channel:
- Hospitals
- E-Commerce
By Disease Indication:
- Diabetes Type 1
- Diabetes Type 2
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
